Medvest Capital

Osteal Therapeutics is a clinical-stage specialty pharmaceutical company focused on developing innovative drug and device combination products aimed at treating musculoskeletal infections. The company’s therapeutics are designed to significantly reduce the mortality, morbidity, and healthcare costs associated with these infections. Osteal Therapeutics offers solutions for orthopedic infections and infected joint prostheses, providing fast and reliable treatment options. This enables orthopedic surgeons to deliver effective care for patients suffering from musculoskeletal diseases, ultimately improving patient outcomes and the overall management of these conditions.

BrightSpec is a company based in Charlottesville, Virginia, specializing in advanced analytical chemistry solutions through its innovative Fourier transform molecular rotational resonance (FT-MRR) spectroscopy platform. This technology, developed by researchers at the University of Virginia, enables comprehensive characterization of chemical molecules, with the capability to differentiate between stereoisomers and isotopes. BrightSpec's platform addresses high-value, time-sensitive analytical challenges that conventional spectroscopy techniques struggle to meet. By eliminating the need for reference samples or separations, its solutions enhance the analysis of complex mixtures, making them particularly valuable for applications in manufacturing process control, quality assurance, environmental monitoring, and formulation research. The company aims to improve the efficiency and accuracy of chemical analysis, thereby transforming the landscape of sample analytics in various industries.

Osteal Therapeutics is a clinical-stage specialty pharmaceutical company focused on developing innovative drug and device combination products aimed at treating musculoskeletal infections. The company’s therapeutics are designed to significantly reduce the mortality, morbidity, and healthcare costs associated with these infections. Osteal Therapeutics offers solutions for orthopedic infections and infected joint prostheses, providing fast and reliable treatment options. This enables orthopedic surgeons to deliver effective care for patients suffering from musculoskeletal diseases, ultimately improving patient outcomes and the overall management of these conditions.

Providence Medical Technology, Inc. is a medical device company specializing in innovative solutions for cervical spine conditions, operating in the United States and internationally. The company has developed a proprietary approach to cervical fusion, offering a range of products designed to treat cervical degenerative disc disease through indirect decompression and fusion. Its product lineup includes the DTRAX Spinal System, which comprises single-use disposable instruments for accessing the spine via posterior surgical incisions; the DTRAX Cervical Cage for treating cervical radiculopathy; the DTRAX Graft, a structural allograft for supporting posterior fusion; and the DTRAX Facet System, a sterile kit containing necessary tools and implants for single-level surgeries. Providence Medical Technology distributes its products through a network of distributors and sales representatives and is headquartered in Lafayette, California.

Providence Medical Technology, Inc. is a medical device company specializing in innovative solutions for cervical spine conditions, operating in the United States and internationally. The company has developed a proprietary approach to cervical fusion, offering a range of products designed to treat cervical degenerative disc disease through indirect decompression and fusion. Its product lineup includes the DTRAX Spinal System, which comprises single-use disposable instruments for accessing the spine via posterior surgical incisions; the DTRAX Cervical Cage for treating cervical radiculopathy; the DTRAX Graft, a structural allograft for supporting posterior fusion; and the DTRAX Facet System, a sterile kit containing necessary tools and implants for single-level surgeries. Providence Medical Technology distributes its products through a network of distributors and sales representatives and is headquartered in Lafayette, California.

Providence Medical Technology, Inc. is a medical device company specializing in innovative solutions for cervical spine conditions, operating in the United States and internationally. The company has developed a proprietary approach to cervical fusion, offering a range of products designed to treat cervical degenerative disc disease through indirect decompression and fusion. Its product lineup includes the DTRAX Spinal System, which comprises single-use disposable instruments for accessing the spine via posterior surgical incisions; the DTRAX Cervical Cage for treating cervical radiculopathy; the DTRAX Graft, a structural allograft for supporting posterior fusion; and the DTRAX Facet System, a sterile kit containing necessary tools and implants for single-level surgeries. Providence Medical Technology distributes its products through a network of distributors and sales representatives and is headquartered in Lafayette, California.